Follow
Krishna Mohan Donavalli
Krishna Mohan Donavalli
Other namesDr. Krishna Mohan Donavalli, KM Donavalli
Senior Scientist - Medicinal Chemistry, Genzada Pharmaceuticals
Verified email at genzada.com - Homepage
Title
Cited by
Cited by
Year
Adducts and dimer compounds synthesized using gk method
KM Donavalli, R Verma, GH Zaid
US Patent App. 18/458,604, 2024
2024
Antimicrobial compounds, synthesis methods, and uses thereof
R Verma, KM Donavalli, GH Zaid
US Patent App. 18/327,213, 2024
2024
Inhibition of COVID-19 virus
GH Zaid, RP Moore, CE West, JH West, KM Donavalli
US Patent 11,576,902, 2023
2023
Harmine synthesis
GH Zaid, KM Donavalli, R Verma
US Patent 11,578,070, 2023
2023
Low-temperature synthesis of thymoquinone and harmaline compounds
GH Zaid, BA Wolf, RE Ropp, KM Donavalli, R Verma
US Patent App. 17/670,264, 2022
2022
Synthesis of Phosphotidylglycerol Receptor: Precursor Preparation
M Ashan, KM Donavalli, DH Burns
The 18th Annual Kansas-IDeA Network of Biomedical Research Excellence …, 2020
2020
Synthesis of small bis-phenolic ether scaffold cationic molecule that binds to phosphatidylglycerol at the membrane interface
KM Donavalli, DH Burns
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 257, 2019
2019
Cationic Liptins as Candidates for Next Generation Antibiotics
T Martin, KM Donavalli, DH Burns
The 16th Annual K-INBRE Symposium, 2018
2018
Synthesis of charged receptors with a bis phenolic ether scaffold
KM Donavalli, DH Burns
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 252, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–9